Upgrade to SI Premium - Free Trial

Cytosorbents (CTSO) Reports In-Line Q3 EPS

November 9, 2017 4:19 PM

Cytosorbents (NASDAQ: CTSO) reported Q3 EPS of ($0.07), in-line with the analyst estimate of ($0.07). Revenue for the quarter came in at $3.45 million versus the consensus estimate of $3.86 million.

For earnings history and earnings-related data on Cytosorbents (CTSO) click here.

Categories

Earnings Guidance

Next Articles